Research suggests that caraway, along with other medicinal plants, is commonly included in food supplements marketed for digestive health conditions such as bloating, dyspepsia, and excess gastric acid, though the current evidence base is limited. The available literature in this area consists largely of reviews of traditional use and marketplace surveys rather than rigorous clinical trials such as randomized controlled trials or meta-analyses specifically evaluating caraway's efficacy. Studies indicate that health claims appearing on supplement labels are frequently grounded in traditional use rather than well-designed clinical research, and a 2025 systematic review of Latvian digestive health supplements found that strong clinical evidence supporting these claims is generally lacking across the category. Overall, the research direction is mixed and inconclusive, with experts calling for better-standardized preparations, more consistent regulatory oversight, and additional clinical investigation before firm conclusions can be drawn about the digestive benefits of caraway-containing products.
Citations from PubMed and preprint sources. Match score (0-100) reflects automated search ranking, not clinical appraisal.
| Title | Type | Year | Direction | Match |
|---|---|---|---|---|
| Medicinal Plants in Food Supplements for Gastrointestinal Disorders: Critical... | Review | 2025 | Mixed | 100 |